Progressive release of vitreomacular traction with aflibercept

Research output: Contribution to journalArticlepeer-review


A patient with combined diabetic macular edema (DME) and vitreomacular traction (VMT) was treated with a series of intravitreal aflibercept (Eylea; Regeneron, Tarrytown, NY) injections. The VMT progressively released during the course of the five intravitreal injections. This release may have been spontaneous, due to a nonspecific mechanical effect from the injections, or due to a pharmacologic effect from the aflibercept. While treating DME, anti-vascular endothelial growth factor agents may have an additional benefit in releasing VMT.

Original languageEnglish (US)
Pages (from-to)477-481
Number of pages5
JournalOphthalmic Surgery Lasers and Imaging Retina
Issue number5
StatePublished - May 2016

ASJC Scopus subject areas

  • Surgery
  • Ophthalmology


Dive into the research topics of 'Progressive release of vitreomacular traction with aflibercept'. Together they form a unique fingerprint.

Cite this